ArticleBlood advances2023
DeFilipp Z, Kim HT, Yang Z, et al. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials. Blood Adv. 2022;6(24):6263-6270.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.